Breaking News

GE introduces Biacore 8K+

The eight-needle high-sensitivity surface plasmon resonance system can automate 4500 drug candidate-disease targets at once

GE Healthcare Life Sciences has introduced Biacore 8K+, an eight-needle high-sensitivity surface plasmon resonance (SPR) system that is able to automate over 4500 drug candidate–disease target binding experiments in one run.    This aims to increase operational efficiency in pharmaceutical discovery and development, quality control, and basic life science research. The Biacore instrument generates high-quality data from interaction experiments, which, when paired with dedicated ease of u...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters